z-logo
open-access-imgOpen Access
Method development for optimised green synthesis of gold nanoparticles from Millettia pinnata and their activity in non‐small cell lung cancer cell lines
Author(s) -
Kumar Gourav,
Ghosh Manik,
Pandey Dev Mani
Publication year - 2019
Publication title -
iet nanobiotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.366
H-Index - 38
eISSN - 1751-875X
pISSN - 1751-8741
DOI - 10.1049/iet-nbt.2018.5410
Subject(s) - colloidal gold , zeta potential , nanoparticle , nuclear chemistry , chemistry , particle size , dynamic light scattering , nanotechnology , materials science
Green synthesis of gold nanoparticles (GNPs) has received substantial attention, because nanoparticles are produced in an eco‐friendly way using biomolecules present in plant extracts in a single step reaction. This research article highlights GNPs obtained using shade‐dried leaf extracts of Millettia pinnata (L.) with aqueous auric chloride (HAuCl 4 ) at ambient temperature. In the present study, GNPs with average particle size 37 nm in size were fabricated. Furthermore, the synthesis method to obtain stable and monodispersed GNPs was advanced by optimising enzyme concentration 100 μg/ml, pH 5.4, substrate concentration 0.45 mM and 12 h time of reaction. The confirmation of GNPs formation and characterisation was followed by UV‐vis‐absorption spectroscopy, dynamic light scattering (DLS), and zeta potential (ZP) for the analysis of shape, size, and stability, respectively. TEM images and powder XRD revealed the GNPs synthesis of spherical‐shaped nanoparticles in the face‐centred cubic arrangement. Cytotoxicity of GNPs was studied against A549 lung cancer cells with IC 50 14.76 μg/ml and found lower as compared to doxorubicin IC 50 11.23 μg/ml but significant enough to be used as a vehicle GNPs produced using green source can be used as significant therapeutic agents and drug delivery carriers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here